| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jasmin Obermanns, Vera Flasbeck, Saskia Steinmann, Georg Juckel, Barbara Emon. Investigation of the Serotonergic Activity and the Serotonin Content in Serum and Platelet, and the Possible Role of the Serotonin Transporter in Patients with Depression. Behavioral sciences (Basel, Switzerland). vol 12. issue 6. 2022-06-23. PMID:35735388. |
investigation of the serotonergic activity and the serotonin content in serum and platelet, and the possible role of the serotonin transporter in patients with depression. |
2022-06-23 |
2023-08-14 |
human |
| Jasmin Obermanns, Vera Flasbeck, Saskia Steinmann, Georg Juckel, Barbara Emon. Investigation of the Serotonergic Activity and the Serotonin Content in Serum and Platelet, and the Possible Role of the Serotonin Transporter in Patients with Depression. Behavioral sciences (Basel, Switzerland). vol 12. issue 6. 2022-06-23. PMID:35735388. |
according to the monoamine hypothesis, the development of depression is associated with dysfunctions of the serotonergic system. |
2022-06-23 |
2023-08-14 |
human |
| Jasmin Obermanns, Vera Flasbeck, Saskia Steinmann, Georg Juckel, Barbara Emon. Investigation of the Serotonergic Activity and the Serotonin Content in Serum and Platelet, and the Possible Role of the Serotonin Transporter in Patients with Depression. Behavioral sciences (Basel, Switzerland). vol 12. issue 6. 2022-06-23. PMID:35735388. |
alterations in the serotonin transporter gene (5-httlpr), the serotonergic activity in the brain, and the content of serotonin (5-ht) have been related to depression and were examined separately by previous studies. |
2022-06-23 |
2023-08-14 |
human |
| Jasmin Obermanns, Vera Flasbeck, Saskia Steinmann, Georg Juckel, Barbara Emon. Investigation of the Serotonergic Activity and the Serotonin Content in Serum and Platelet, and the Possible Role of the Serotonin Transporter in Patients with Depression. Behavioral sciences (Basel, Switzerland). vol 12. issue 6. 2022-06-23. PMID:35735388. |
since the serotonergic activity, peripheral serotonin content, and 5-httlpr were unrelated, the results suggest independent alterations of central and peripheral serotonergic systems in depression. |
2022-06-23 |
2023-08-14 |
human |
| Jasmin Obermanns, Vera Flasbeck, Saskia Steinmann, Georg Juckel, Barbara Emon. Investigation of the Serotonergic Activity and the Serotonin Content in Serum and Platelet, and the Possible Role of the Serotonin Transporter in Patients with Depression. Behavioral sciences (Basel, Switzerland). vol 12. issue 6. 2022-06-23. PMID:35735388. |
in line with this finding, serotonergic activity was related to anxiety and depression symptoms. |
2022-06-23 |
2023-08-14 |
human |
| Stéphane Prange, Hélène Klinger, Chloé Laurencin, Teodor Danaila, Stéphane Thoboi. Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment. Drugs & aging. 2022-06-15. PMID:35705848. |
in particular, the evolution of serotonergic, noradrenergic, and dopaminergic dysfunction and abnormalities of limbic circuits across time, involving the anterior cingulate and orbitofrontal cortices, amygdala, thalamus and ventral striatum, help to delineate the variable expression of depression in patients with prodromal, early and advanced pd. |
2022-06-15 |
2023-08-14 |
Not clear |
| Masashi Mizutani, Terunori Sano, Masayuki Ohira, Masaki Taka. Neuropathological studies of Serotonergic and Noradrenergic Systems in Lewy Body Disease Patients with Delusion or Depression. Psychiatry and clinical neurosciences. 2022-06-13. PMID:35695782. |
neuropathological studies of serotonergic and noradrenergic systems in lewy body disease patients with delusion or depression. |
2022-06-13 |
2023-08-14 |
Not clear |
| Tomohiro Nabekura, Shinya Ishikawa, Makoto Tanase, Taichi Okumura, Tatsuya Kawasak. Antidepressants induce toxicity in human placental BeWo cells. Current research in toxicology. vol 3. 2022-05-23. PMID:35602006. |
selective serotonin reuptake inhibitors (ssris), serotonin and noradrenaline reuptake inhibitors (snris), and noradrenergic and specific serotonergic antidepressants (nassas) are broadly used for the treatment of depression. |
2022-05-23 |
2023-08-13 |
human |
| Anders Jorgensen, Kristin Köhler-Forsberg, Trine Henriksen, Allan Weimann, Ivan Brandslund, Christina Ellervik, Henrik E Poulsen, Gitte Moos Knudsen, Vibe G Frokjaer, Martin B Jorgense. Systemic DNA and RNA damage from oxidation after serotonergic treatment of unipolar depression. Translational psychiatry. vol 12. issue 1. 2022-05-16. PMID:35577781. |
systemic dna and rna damage from oxidation after serotonergic treatment of unipolar depression. |
2022-05-16 |
2023-08-13 |
Not clear |
| Maria Del Pilar Carrera-González, Vanesa Cantón-Habas, Manuel Rich-Rui. Aging, depression and dementia: The inflammatory process. Advances in clinical and experimental medicine : official organ Wroclaw Medical University. 2022-05-13. PMID:35546565. |
in depression, an increase in inflammatory cytokines has been described, which would justify the serotonergic, noradrenergic and dopaminergic dysfunction of depression. |
2022-05-13 |
2023-08-13 |
Not clear |
| Suzanne Vrshek-Schallhorn, Gail M Corneau, Alessandra R Grillo, Vaibhav R Sapuram, Thomas Plieger, Martin Reute. Additive serotonergic genetic sensitivity and cortisol reactivity to lab-based social evaluative stress: Influence of severity across two samples. Psychoneuroendocrinology. vol 142. 2022-05-07. PMID:35525123. |
prior work demonstrates that an additive serotonergic multilocus genetic profile score (mgps) predicts amplified risk for depression following significant life stress, and that it interacts with elevations in the cortisol awakening response to predict depression. |
2022-05-07 |
2023-08-13 |
Not clear |
| Gita Kholghi, Maliheh Eskandari, Mohammad-Saleh Shokouhi Qare Saadlou, Mohammad-Reza Zarrindast, Salar Vasegh. Night shift hormone: How does melatonin affect depression? Physiology & behavior. 2022-05-03. PMID:35504318. |
the interaction effect between melatonin or agomelatine and serotonergic signaling has a significant effect on depression. |
2022-05-03 |
2023-08-13 |
Not clear |
| Vivian B Neis, Isabel Werle, Morgana Moretti, Priscila B Rosa, Anderson Camargo, Yasmim de O Dalsenter, Nicolle Platt, Axel F Rosado, William D Engel, Gudrian Ricardo L de Almeida, Ingrid Selhorst, Alcir Luiz Dafre, Ana Lúcia S Rodrigue. Involvement of serotonergic neurotransmission in the antidepressant-like effect elicited by cholecalciferol in the chronic unpredictable stress model in mice. Metabolic brain disease. 2022-04-18. PMID:35435610. |
our results indicate that cholecalciferol has an antidepressant-like effect in mice by modulating the serotonergic system and support the assumption that cholecalciferol may have beneficial effects for the management of depression. |
2022-04-18 |
2023-08-13 |
mouse |
| Chong Che. Recent advances in the study of the comorbidity of depressive and anxiety disorders. Advances in clinical and experimental medicine : official organ Wroclaw Medical University. 2022-04-08. PMID:35394125. |
whereas previous neurobiological and neuroendocrinological studies reported common alterations in prefrontal-limbic pathways, serotonergic projections and the hypothalamic-pituitary-adrenal (hpa) axis, recent research suggests that distinct neural circuits and heterogeneous changes in hpa activity may exist in depression when compared to anxiety. |
2022-04-08 |
2023-08-13 |
Not clear |
| Yu Han, Meng Zhang, Jiahui Duan, Leyi Li, Jinge Du, Hui Cheng, Sheng Zhang, Yanhui Zhai, Xinglan An, Qi Li, Xueming Zhang, Ziyi Li, Bo Tan. Maternal Prepregnancy 5-Hydroxytryptamine Exposure Affects the Early Development of the Fetus. Frontiers in physiology. vol 13. 2022-04-04. PMID:35370795. |
in recent decades, the increasing incidence of depression has contributed to an increase in the use of serotonergic drugs, such as antidepressants, which predisposes humans to serotonin syndrome. |
2022-04-04 |
2023-08-13 |
mouse |
| Enav Z Zusman, Alekhya Lavu, Colleen Pawliuk, Jodi Pawluski, Sarah M Hutchison, Robert W Platt, Tim F Oberlande. Associations Between Prenatal Exposure to Serotonergic Medications and Biobehavioral Stress Regulation: Protocol for a Systematic Review and Meta-analysis. JMIR research protocols. vol 11. issue 3. 2022-03-28. PMID:35343913. |
up to 20% of mothers experience antenatal depression and approximately 30% of these women are treated with serotonergic psychotropic pharmacological therapy during pregnancy. |
2022-03-28 |
2023-08-13 |
Not clear |
| Zubeyde Ercan, Meryem Sedef Dogru, Nazife Ulker Ertugrul, Ahmet Yardimci, Sinan Canpola. Beneficial effects of irisin in experimental paroxetine-induced hyperprolactinemia. Endocrine. 2022-02-28. PMID:35226247. |
it is known that selective serotonin reuptake inhibitors (ssris), represent an important and effective treatment of depression and other psychological disorders, these medications can increase prolactin levels mainly through activation of the serotonergic pathway. |
2022-02-28 |
2023-08-13 |
Not clear |
| Robert B Kargbo, Alexander M Sherwood, Poncho Meisenheimer, Kelsey Lenoch, Solomon Abeb. Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD). ACS omega. vol 7. issue 6. 2022-02-21. PMID:35187358. |
psilocybin, a serotonergic agonist, was granted a "breakthrough therapy" status by the food and drug administration for clinical trials involving major depressive disorder and treatment-resistant depression. |
2022-02-21 |
2023-08-13 |
Not clear |
| Veysel Baskin, Ezgi Eroglu, Nusin Harmanci, Kevser Ero. Antinociceptive, anxiolytic and depression like effects of hydrogen sulfide, nitric oxide and carbon monoxide in rats and the role of opioidergic and serotonergic systems in antinociceptive activity. Fundamental & clinical pharmacology. 2022-01-28. PMID:35090186. |
antinociceptive, anxiolytic and depression like effects of hydrogen sulfide, nitric oxide and carbon monoxide in rats and the role of opioidergic and serotonergic systems in antinociceptive activity. |
2022-01-28 |
2023-08-13 |
rat |
| A Ghaderi, E C Brown, D L Clark, R Ramasubbu, Z H T Kiss, A B Protzne. Role of the serotonergic system in subcallosal DBS for treatment-resistant depression. Brain stimulation. 2021-12-30. PMID:34968745. |
role of the serotonergic system in subcallosal dbs for treatment-resistant depression. |
2021-12-30 |
2023-08-13 |
Not clear |